Poznan University of Medical Sciences is a prominent Polish medical university, located in the city of Poznań in western Poland. It traces its beginnings to the foundation of Poznań University in 1919, and was formed as a separate institution in 1950. It gained the status of university in 2007.

During the past decade, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu" #1 sponsor was "Eisai Limited" with 2 trials, followed by "Actelion" with 1 trials sponsored, "Dompé Farmaceutici S.p.A" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Hospital Universitario Getafe" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu" #1 collaborator was "ACE Pharmaceuticals BV" with 1 trials as a collaborator, "Fundación para la Investigación del Hospital Clínico de Valencia" with 1 trials as a collaborator, "Helsingin Ja Uudenmaan Sairaanhoitopiirin" with 1 trials as a collaborator, "KU Leuven" with 1 trials as a collaborator and "Oslo University Hospital" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu" are "Epilepsy" (2 trials), "Acute Respiratory Failure" (1 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Coronary Disease" (1 trials) and "Cystic Fibrosis" (1 trials). Many other conditions were trialed in "Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu" in a lesser frequency.

Most popular intervention types in "Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu" are "Drug" (9 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Zonisamide" (2 trials), "Allopurinol" (1 trials), "Atezolizumab" (1 trials) and "BN83495" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu has several departments that took part in Clinical trials: "Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences" - 6 trials, "AKADEMIA MEDYCZNA im. Karola Marcinkowskiego w Poznaniu Katedra I Klinika Neurologii Wieku Rozwojowego" - 2 trials, "Katedra i Klinika Neurologii Wieku Rozwojowego" - 2 trials